With more than 300 companies filing for IPOs, the momentum is set to carry into 2026
[SINGAPORE/HONG KONG] Several Chinese companies that raised about HK$7 billion (S$1.2 billion) combined in initial public offerings (IPOs) rallied strongly on their Hong Kong debuts on Tuesday (Dec 30).
This rounded off a resurgent year for listings, as the city dominated Asian equity capital markets in 2025.
The strong starts also signal renewed investor confidence and optimism around tech-driven growth, underpinned by regulatory changes and robust liquidity.
Market participants said the momentum could set the tone for 2026 as Hong Kong reasserts itself as a key listing venue.
Average first-day gains for Hong Kong IPOs in 2025 stood at about 40 per cent, said the Hong Kong Stock Exchange (HKEX).
As at Tuesday, IPOs in the city had raised HK$285.8 billion from 119 listings, HKEX added.
All debutants finished the day above their IPO prices.
“This year’s actually been the best we’ve had since Ant’s IPO got pulled (in 2020),” said George Au, deputy sales director at Phillip Securities.
He added that a margin loan boom, successful listings such as Mixue and CATL, and the allocation rule changes in August have all helped boost sentiment.
InSilico Medicine, a generative artificial intelligence (AI) drug discovery firm, closed up nearly 25 per cent.
Beijing 51World Digital Twin Technology, a software company, ended some 30 per cent higher. USAS Building System, an industrial steel-structure maker, climbed 7.6 per cent. Shanghai Forest Cabin Cosmetics Group, a premium skincare brand, rose more than 9 per cent.
Shenzhen Xunce Technology and OneRobotics closed with minor gains.
“The China market warrants a deeper look at all these emerging tech, robotics and AI companies that are tapping the Hong Kong capital market for funding and growth,” said Mac El-Omari, co-founder of 6E Capital, a family office that partners with 51World, noting the majority of capital being raised now is local.
New IPO launches
Three Chinese firms launched Hong Kong share sales on Tuesday, adding more than HK$9 billion to the city’s IPO pipeline.
Knowledge Atlas Technology, or Zhipu AI, is marketing 37.4 million H-shares at HK$116.20 apiece, to raise HK$4.35 billion.
Chipmaker Shanghai Iluvatar CoreX Semiconductor is offering 25.4 million shares at HK$144.60 for proceeds of HK$3.67 billion, while surgical robotics maker Shenzhen Edge Medical plans to sell 27.7 million shares at HK$43.24 each, to raise about HK$1.2 billion.
All three are scheduled to start trading on Jan 8.
The six debuts and three new launches highlight Hong Kong’s resurgence as an IPO hub.
With more than 300 companies filing to list, the momentum is set to carry into 2026.
Semiconductor designer Shanghai Biren Technology is set to debut on Jan 2 to kick off new listings for 2026, followed by AI startup MiniMax, which could launch its offering as soon as next week. REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
